Severe hypersensitivity pneumonitis associated with everolimus therapy for neuroendocrine tumour: a case report

BACKGROUND: Novel therapeutic agents are currently being investigated for neuroendocrine tumour treatment. CASE PRESENTATION: We report here on the case of a patient presenting with hypersensitivity pneumonitis while being treated with everolimus, a mammalian target of rapamycin (mTOR) inhibitor. CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Sibertin-Blanc, Camille, Norguet, Emmanuelle, Duluc, Muriel, Louis, Guillaume, Seitz, Jean-François, Dahan, Laetitia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843542/
https://www.ncbi.nlm.nih.gov/pubmed/24245774
http://dx.doi.org/10.1186/1756-0500-6-471
_version_ 1782293061939757056
author Sibertin-Blanc, Camille
Norguet, Emmanuelle
Duluc, Muriel
Louis, Guillaume
Seitz, Jean-François
Dahan, Laetitia
author_facet Sibertin-Blanc, Camille
Norguet, Emmanuelle
Duluc, Muriel
Louis, Guillaume
Seitz, Jean-François
Dahan, Laetitia
author_sort Sibertin-Blanc, Camille
collection PubMed
description BACKGROUND: Novel therapeutic agents are currently being investigated for neuroendocrine tumour treatment. CASE PRESENTATION: We report here on the case of a patient presenting with hypersensitivity pneumonitis while being treated with everolimus, a mammalian target of rapamycin (mTOR) inhibitor. CONCLUSION: Side effects of everolimus should be familiar to clinicians, including nonspecialists, and be monitored carefully to allow for prompt management.
format Online
Article
Text
id pubmed-3843542
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38435422013-11-30 Severe hypersensitivity pneumonitis associated with everolimus therapy for neuroendocrine tumour: a case report Sibertin-Blanc, Camille Norguet, Emmanuelle Duluc, Muriel Louis, Guillaume Seitz, Jean-François Dahan, Laetitia BMC Res Notes Case Report BACKGROUND: Novel therapeutic agents are currently being investigated for neuroendocrine tumour treatment. CASE PRESENTATION: We report here on the case of a patient presenting with hypersensitivity pneumonitis while being treated with everolimus, a mammalian target of rapamycin (mTOR) inhibitor. CONCLUSION: Side effects of everolimus should be familiar to clinicians, including nonspecialists, and be monitored carefully to allow for prompt management. BioMed Central 2013-11-18 /pmc/articles/PMC3843542/ /pubmed/24245774 http://dx.doi.org/10.1186/1756-0500-6-471 Text en Copyright © 2013 Sibertin-Blanc et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Sibertin-Blanc, Camille
Norguet, Emmanuelle
Duluc, Muriel
Louis, Guillaume
Seitz, Jean-François
Dahan, Laetitia
Severe hypersensitivity pneumonitis associated with everolimus therapy for neuroendocrine tumour: a case report
title Severe hypersensitivity pneumonitis associated with everolimus therapy for neuroendocrine tumour: a case report
title_full Severe hypersensitivity pneumonitis associated with everolimus therapy for neuroendocrine tumour: a case report
title_fullStr Severe hypersensitivity pneumonitis associated with everolimus therapy for neuroendocrine tumour: a case report
title_full_unstemmed Severe hypersensitivity pneumonitis associated with everolimus therapy for neuroendocrine tumour: a case report
title_short Severe hypersensitivity pneumonitis associated with everolimus therapy for neuroendocrine tumour: a case report
title_sort severe hypersensitivity pneumonitis associated with everolimus therapy for neuroendocrine tumour: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843542/
https://www.ncbi.nlm.nih.gov/pubmed/24245774
http://dx.doi.org/10.1186/1756-0500-6-471
work_keys_str_mv AT sibertinblanccamille severehypersensitivitypneumonitisassociatedwitheverolimustherapyforneuroendocrinetumouracasereport
AT norguetemmanuelle severehypersensitivitypneumonitisassociatedwitheverolimustherapyforneuroendocrinetumouracasereport
AT dulucmuriel severehypersensitivitypneumonitisassociatedwitheverolimustherapyforneuroendocrinetumouracasereport
AT louisguillaume severehypersensitivitypneumonitisassociatedwitheverolimustherapyforneuroendocrinetumouracasereport
AT seitzjeanfrancois severehypersensitivitypneumonitisassociatedwitheverolimustherapyforneuroendocrinetumouracasereport
AT dahanlaetitia severehypersensitivitypneumonitisassociatedwitheverolimustherapyforneuroendocrinetumouracasereport

Ejemplares similares